| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Processa Pharmaceuticals, Inc. (PCSA) has 10 insiders with recent SEC Form 4 filings, including 11 buys and 3 sells. PCSA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 300.0K | $819.0K | - | |
| ? | 300.0K | $819.0K | - | |
| CEO | 256.0K | $698.9K | - | |
| Other | 111.0K | $303.0K | - | |
| CFO | 108.0K | $294.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2023 | Young David | President &CEO | Buy | 20,000 | $0.55 | $10,998.00 | +4.9% | -2.5% | -83.3% | |
| Apr 13, 2023 | Young David | President &CEO | Buy | 60,000 | $0.48 | $29,000.00 | +5.4% | +6.3% | -82.2% | |
| May 17, 2022 | Lin Patrick | Chief Business - Strategy Off | Buy | 2,000 | $1.59 | $3,189.00 | +0.5% | +72.5% | -65.1% | |
| Apr 7, 2022 | Lin Patrick | Chief Business - Strategy Off | Buy | 2,000 | $3.29 | $6,587.08 | +0.2% | -7.9% | -86.8% | |
| Jan 27, 2022 | Yorke Justin W56 | Director | Sell | 1,854 | $3.30 | $6,118.20 | -0.3% | -19.3% | -73.5% | |
| Dec 14, 2021 | Lin Patrick | Chief Business - Strategy Off | Buy | 3,000 | $4.00 | $12,000.00 | +0.7% | -12.7% | -51.1% | |
| Dec 14, 2021 | Lin Patrick | Chief Business - Strategy Off | Buy | 3,000 | $4.00 | $12,000.00 | +0.7% | -12.7% | -51.1% | |
| Dec 6, 2021 | Yorke Justin W56 | Director | Sell | 9,700 | $4.78 | $46,382.78 | -0.9% | -23.4% | -60.6% | |
| Dec 3, 2021 | Lin Patrick | Chief Business - Strategy Off | Buy | 3,500 | $4.80 | $16,795.10 | +0.8% | -18.9% | -60.3% | |
| Aug 26, 2021 | Lin Patrick | Chief Business - Strategy Off | Buy | 4,000 | $6.02 | $24,088.00 | +1.0% | -5.5% | -50.4% |